The investigation is complete: the hair loss medication is effective

A new hair loss treatment, VDPHL01, has shown promising results in clinical trials conducted by Veradermics. The study involved 536 men with mild to moderate hair loss over six months. Participants taking one or two daily doses of the 8.5 mg tablet experienced significant hair growth compared to the placebo group. The active ingredient, minoxidil, is already known for its effectiveness in hair regrowth. The company plans further studies, including one on women, with results expected in early 2027.